LenioBio is a life sciences biotech company, pioneering a disruptive protein expression platform.
Using our ALiCE technology, we enable our customers – researchers and biopharma manufacturers -to streamline and accelerate their protein discovery, development, and production processes.
We aim to simplify manufacturing and speed up the delivery of drugs to the patient.